Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2022-03-18 00:00:00 ET · period of report 2020-06-30 · accession 0001179110-22-002329 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-18 | 2020-06-30+ | KNSA | Megna Michael R | CAO | A - Grant | $11.03 | +2,287 | 2,771 | +473% | +$25.2K |
| D | 2022-03-18 | 2022-03-16 | KNSA | Megna Michael R | CAO | M - OptEx | — | +775 | 4,199 | +23% | — |
| D | 2022-03-18 | 2022-03-16 | KNSA | Megna Michael R | CAO | F - Tax | $10.13 | -269 | 3,930 | -6% | -$2,725 |
| D | 2022-03-18 | 2022-03-16 | KNSA | Megna Michael R | CAO | M - OptEx | $0.00 | -775 | 2,323 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2022-01-15 | A | A | 653 | $9.63 | 3,424 | D | — | — | |
| 2 | Common | Class A Common Share | 2022-03-16 | M | A | 775 | — | 4,199 | D | — | — | (F5) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 3 | Common | Class A Common Share | 2022-03-16 | F | D | 269 | $10.13 | 3,930 | D | — | — | |
| 4 | Common | Class A Common Share | 2020-06-30 | A | A | 641 | $9.51 | 1,778 | D | — | — | |
| 5 | Common | Class A Common Share | 2020-12-31 | A | A | 405 | $15.02 | 2,183 | D | — | — | |
| 6 | Common | Class A Common Share | 2021-07-15 | A | A | 588 | $11.49 | 2,771 | D | — | — | |
| 7 | Derivative | Restricted Share Unit | 2022-03-16 | M | D | 775 | $0.00 | 2,323 | D | — · — to — | 775 Class A Common Share | (F5) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F6) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 16, 2021. |